Suraksha Diagnostic shares saw upward momentum today after Dr. Somnath Chatterjee, Promoter, Chairman & Joint Managing Director, acquired 8,190 equity shares on August 12, 2025, via open market transaction.
The acquisition resulted in an increase in Dr. Chatterjee's total holdings, leading to a shift in the Promoter and Promoter Group's shareholding structure.
Acquisition Details
Dr. Chatterjee's purchase of 8,190 shares represents 0.016% of the total share/voting capital. The transaction was executed through an open market purchase.
Pre- and Post-Acquisition Shareholding
Prior to the acquisition, Dr. Chatterjee held 26,22,343 shares, representing 5.034% of the total share/voting capital. Following the acquisition, his holding increased to 26,30,533 shares, or 5.051% of the total share/voting capital.
| Particulars | Before Acquisition | After Acquisition |
|---|---|---|
| Shares carrying voting rights | 26,22,343 (5.034%) | 26,30,533 (5.051%) |
Additional Information
The company's equity share capital remains unchanged at ₹10.41 Crores, comprised of 5,20,80,758 equity shares priced at ₹2 each. The acquisition does not impact the total diluted share/voting capital.
Suraksha Diagnostic has requested exchanges to update records reflecting the revised shareholding.
This disclosure is pursuant to Regulation 29(2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
Suraksha Diagnostic has requested exchanges to update records reflecting the revised shareholding.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.
